Literature DB >> 1690731

Cell-type specific and differential regulation of the human metallothionein genes. Correlation with DNA methylation and chromatin structure.

N Jahroudi1, R Foster, J Price-Haughey, G Beitel, L Gedamu.   

Abstract

The expression of three human metallothionein genes, MT-IIA, MT-IF, and MT-IG was studied in the human hepatoblastoma (HepG2), the hepatocarcinoma (Hep3B2), the embryonic kidney (Hek 293), and the lymphoblastoid-derived (Wi-L2) cell lines. The pattern of expression of each specific MT gene in response to various heavy metals was different among the four cell lines studied indicating differential regulation of MT gene expression. The MT-IF or MT-IG and the MT-IIA genes were regulated in a cell-type specific manner in response to heavy metals and dexamethasone, respectively. DNA methylation was shown to be correlated to cell-type specific regulation of MT gene expression since 5-azacytidine treatment resulted in the expression of the MT-IF and MT-IG genes in response to cadmium and zinc in Wi-L2 cells, of the MT-IIA gene in response to dexamethasone in Wi-L2 cells, and of the MT-IG in response to zinc and copper in Hek 293 cells. Furthermore, transfection studies indicated that all the trans-acting factors necessary for the expression of these genes were present and functional in Wi-L2 and Hek 293 cells. The differential level of expression of the MT-IF and MT-IG genes in response to heavy metals in the Hek 293 cell line was shown to be correlated to their chromatin structure.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1690731

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Absence of Metallothionein 3 Expression in Breast Cancer is a Rare, But Favorable Marker of Outcome that is Under Epigenetic Control.

Authors:  Seema Somji; Scott H Garrett; Xu Dong Zhou; Yun Zheng; Donald A Sens; Mary Ann Sens
Journal:  Toxicol Environ Chem       Date:  2010-10       Impact factor: 1.437

2.  Mercury distribution and renal metallothionein induction after subchronic oral exposure in rats.

Authors:  M A Morcillo; J Santamaria
Journal:  Biometals       Date:  1996-07       Impact factor: 2.949

3.  Mammalian cell-line based toxicological evaluation of paper mill black liquor treated in a soil microcosm by indigenous alkalo-tolerant Bacillus sp.

Authors:  Monika Mishra; Mihir Tanay Das; Indu Shekhar Thakur
Journal:  Environ Sci Pollut Res Int       Date:  2013-10-30       Impact factor: 4.223

4.  Dependence of transcriptional repression on CpG methylation density.

Authors:  C L Hsieh
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

5.  Use of metallothioneins as biomarkers for environmental quality assessment in the Gulf of Gabès (Tunisia).

Authors:  Rim Ladhar-Chaabouni; Monia Machreki-Ajmi; Amel Hamza-Chaffai
Journal:  Environ Monit Assess       Date:  2011-05-25       Impact factor: 2.513

6.  Metallothionein accretion in human hepatic cells is linked to cellular proliferation.

Authors:  R Studer; C P Vogt; M Cavigelli; P E Hunziker; J H Kägi
Journal:  Biochem J       Date:  1997-11-15       Impact factor: 3.857

7.  Effect of cadmium treatment on the expression of chimeric genes in transgenic tobacco seedlings and calli.

Authors:  Ivan Stefanov; Joachim Frank; Lashitew Gedamu; Santosh Misra
Journal:  Plant Cell Rep       Date:  1997-02       Impact factor: 4.570

8.  Ribozyme mediated degradation of beta-amyloid peptide precursor mRNA in COS-7 cells.

Authors:  R B Denman; M Smedman; W Ju; R Rubenstein; A Potempska; D L Miller
Journal:  Nucleic Acids Res       Date:  1994-06-25       Impact factor: 16.971

9.  Reactive nitrogen intermediates, antinuclear antibodies and copper-thionein in serum of patients with rheumatic diseases.

Authors:  R Miesel; M Zuber
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

10.  Copper-dependent antioxidase defenses in inflammatory and autoimmune rheumatic diseases.

Authors:  R Miesel; M Zuber
Journal:  Inflammation       Date:  1993-06       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.